| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.075 | 0.6 |